PMID- 10992259 OWN - NLM STAT- MEDLINE DCOM- 20001109 LR - 20131121 IS - 0040-3709 (Print) IS - 0040-3709 (Linking) VI - 62 IP - 4 DP - 2000 Oct TI - Pathogenesis of retinoic acid-induced abnormal pad patterns on mouse volar skin. PG - 181-8 AB - BACKGROUND: Abnormal dermatoglyphs on human volar skin have been reported in many syndromes, but little is known about the pathogenesis. Patterns of pads on rodent limb volar skin are homologous to human dermatoglyphs. METHODS: In previous studies, we showed that transplacental exposure to teratogens induced abnormal pads in mouse fetuses. Moreover, teratogens caused abnormal pad patterns at levels below those that caused skeletal malformations. In this study, we examined morphology and cytokinetics in developing abnormal pads. Pregnant mice were treated with all-trans-retinoic acid at 20 mg/kg orally at embryonal day (E) 12.5 (vaginal plug = E0). The hindlimbs of the embryos were harvested and observed under a light microscope and by scanning electron microscopy. Cell proliferation and cell death were estimated by 5-bromo-2'-deoxyuridine (BrdU) labeling, Nile blue A vital staining, and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL). RESULTS: Retinoic acid induced aplasia of the fibular tarsal pad and supernumerary interdigital pads on hindlimbs. Cell proliferation was observed in the area of developing pad, but cell death was very rarely seen in either normal or abnormal pads. CONCLUSIONS: Retinoic acid disturbed pad patterning as a whole rather than individual pad formation. CI - Copyright 2000 Wiley-Liss, Inc. FAU - Mori, N AU - Mori N AD - Department of Orthopaedic Surgery, Hiroshima University School of Medicine, Hiroshima, Japan. mori@mcai.med.hiroshima-u.ac.jp FAU - Tsugane, M H AU - Tsugane MH FAU - Yamashita, K AU - Yamashita K FAU - Ikuta, Y AU - Ikuta Y FAU - Yasuda, M AU - Yasuda M LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Teratology JT - Teratology JID - 0153257 RN - 5688UTC01R (Tretinoin) RN - G34N38R2N1 (Bromodeoxyuridine) SB - IM CIN - Teratology. 2000 Oct;62(4):178-80. PMID: 10992258 MH - Abnormalities, Drug-Induced/*etiology/pathology MH - Animals MH - Bromodeoxyuridine/metabolism MH - Cell Death/drug effects MH - Cell Survival/drug effects MH - Embryo, Mammalian/*drug effects MH - Female MH - Fibula/pathology/ultrastructure MH - Foot Deformities, Congenital/*chemically induced/pathology MH - Hindlimb/*abnormalities/drug effects/embryology MH - In Situ Nick-End Labeling/methods MH - Mice MH - Microscopy, Electron, Scanning MH - Pregnancy MH - Skin/*drug effects/embryology MH - Skin Abnormalities/*chemically induced/pathology MH - Tretinoin/*toxicity EDAT- 2000/09/19 11:00 MHDA- 2001/02/28 10:01 CRDT- 2000/09/19 11:00 PHST- 2000/09/19 11:00 [pubmed] PHST- 2001/02/28 10:01 [medline] PHST- 2000/09/19 11:00 [entrez] AID - 10.1002/1096-9926(200010)62:4<181::AID-TERA3>3.0.CO;2-I [pii] AID - 10.1002/1096-9926(200010)62:4<181::AID-TERA3>3.0.CO;2-I [doi] PST - ppublish SO - Teratology. 2000 Oct;62(4):181-8. doi: 10.1002/1096-9926(200010)62:4<181::AID-TERA3>3.0.CO;2-I.